Barrington Research Maintains Outperform on Merit Medical Systems, Raises Price Target to $114
Portfolio Pulse from Benzinga Newsdesk
Barrington Research has maintained an 'Outperform' rating on Merit Medical Systems and raised the price target from $100 to $114, indicating a positive outlook for the company's stock.
September 20, 2024 | 3:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barrington Research has maintained an 'Outperform' rating on Merit Medical Systems and increased the price target from $100 to $114, suggesting a positive short-term outlook for the stock.
The 'Outperform' rating and increased price target from $100 to $114 by Barrington Research indicate a strong positive sentiment towards Merit Medical Systems. This is likely to boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100